AI in Neurology Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Increasing Data Availability
   3. Market Restraints
      1. Data Privacy and Security Concerns
      2. Limited Clinical Validation and Adoption
   4. Market Opportunities
      1. Growing demand for software-as-a-service (SaaS)
   5. Market Trends
      1. Integration of Multimodal Data Sources
      2. Adoption of Explainable AI (XAI) in Neurology
5. MARKET SEGMENTATION
   1. By Indication
      1. Neuro-technology
      2. Neurosurgery
   2. By Application
      1. Screening & Diagnosis
      2. Treatment
      3. Research & Development
      4. Training
      5. Surgical Planning and Rehabilitation
      6. Others
   3. By Type
      1. Oncology
      2. Neurodegeneration
      3. Neurovascular
      4. Traumatic Brain Injury
      5. Spinal Cord Injury
   4. By Technology
      1. Machine Learning and Deep Learning
      2. Natural Language Processing [NLP]
      3. Others
   5. By End User
      1. Hospitals
      2. Diagnosis Centres
      3. Others
   6. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. ActivSurgical Inc. (U.S.)
      2. Brainomix Limited (U.K.)
      3. Caresyntax Corp (U.S.)
      4. ExplORer Surgical Corp. (U.S.)
      5. LeanTaaS Inc. (U.S.)
      6. Medtronic Plc (Ireland)
      7. Neosama Inc. (Israel)
      8. Surgalign Spine Technology Inc. (U.S.)
      9. Scalpel Limited (U.K.)
      10. Theator Inc. (U.S.)
   2. MARKET OPPORTUNITIES AND FUTURE TRENDS

Frequently Asked Questions

Q.1. What is the projected market value of the global AI in Neurologymarket?

The global market of AI in Neurology is projected to reach USD 1,408.38 Mn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global AI in Neurology market?

The global AI in Neurology market has an estimated annual growth rate of 40.2%. 

Q.3. What are the recent trends of AI in Neurology market?

Integration of multimodal data sources and adoption of explainable AI(XAI) in Neurology are some of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in AI in Neurology ?

The major companies profiled in this report include ActivSurgical Inc. (U.S.), Brainomix Limited (U.K.), Caresyntax Corp (U.S.), ExplORer Surgical Corp. (U.S.), LeanTaaS Inc. (U.S.), Medtronic Plc (Ireland), Neosama Inc. (Israel), Surgalign Spine Technology Inc. (U.S.), Scalpel Limited (U.K.), Theator Inc. (U.S.), among others.

Q.5. Which region is estimated to held highest CAGR inAI in Neurologymarket?

North America is estimated to hold biggest share in the market for AI in Neurology.